|
|
|
|
|
by officialchicken
3764 days ago
|
|
A lot and not enough. My guess/hope is 40% of south Florida startups? 80% of Minneapolis St. Paul startups? 33% of San Diego startups? Look around those locations and Boston. I used to do surgical AR. The immediate-now-future is nanodevices, rDNA pharma / gene therapy, and more exotic chemistry. Hardware and software only play a supporting role and smaller role in the final clinically approved therapy. No matter your background all require organic, molecular and various biochemistry or medical skills - probably not as much mechanical engineering as you hope now that CRISPR is here. |
|